[RGLS] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -8.11%
YoY- 47.21%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 0 5,000 18 18 18 204 -
PBT -7,551 -8,628 -1,523 -5,423 -10,273 -15,835 -19,515 -14.63%
Tax -12 1 1 87 201 -7 4 -
NP -7,539 -8,628 -1,524 -5,423 -10,273 -15,828 -19,519 -14.65%
Tax Rate - - - - - - - -
Total Cost 7,539 8,628 6,524 5,441 10,291 15,846 19,723 -14.80%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 0.00 -30.48 -30,127.78 -57,072.22 -87,933.33 -9,568.14 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.50 -0.99 -0.40 -2.60 -11.80 -21.09 -44.33 -52.62%
EPS Diluted -0.50 -0.99 -0.40 -2.60 -11.80 -21.09 -44.33 -52.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.